Ambicare Health and Healthxchange Pharmacy have announced an exclusive UK Sales & Marketing Agreement for the distribution of Lustre Pro – a third generation blue light technology device for the treatment of mild to moderate acne.
Today, Paul James Donnelly, CEO of Ambicare Health Ltd, announced a new and exciting development for the continued distribution and support of the Lustre Professional device for UK clinics.
Lustre Pure Light was launched 2 years ago and is now available in over 200 UK clinics with the faster Lustre Professional device replacing the Classic device in July 2013.
Paul James Donnelly, commented ‘We are delighted to announce this new and exciting partnership with Healthxchange Pharmacy who will provide full national coverage to our UK clinic customers. We believe that Healthxchange Pharmacy’s well-earned reputation for customer service and support, as well as their award winning skin care range from Obagi Medical, which includes the unique acne system CLENZIderm M.D.TM, will help to provide synergistic benefits to acne sufferers who choose the clinic route for their treatment’.
Karen Hill, Managing Director for Healthxchange Pharmacy said ‘We are always on the look out for truly effective technology. Lustre Pro has shown itself it to deliver results for the acne sufferer. The psychological impact on someone with acne is often hugely underrated and we are pleased to be able to offer a solution that avoids antibiotic and oral treatments’.
From 10th March 2014 all orders for Lustre Pro should be placed directly with Healthxchange Pharmacy. Telephone: +44 (0)1481 736837 or email: email@example.com